FDA Approved: Yes (First approved December 5, 2017) Brand name: Ozempic Generic name: semaglutide Dosage form: Injection and Tablets Company: Novo Nordisk Treatment for: Type 2 Diabetes, Cardiovascular Risk Reduction, Chronic Kidney Disease Add Drugs.com on Google Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog for the treatment type 2 diabetes, and to reduce the risk of major cardiovascular events and worsening kidney disease in patients with type 2 diabetes
But like all GLP-1 medications, it comes with potential side effects worth understanding before you start
However, millions of patients across the US use these medications, according to Stat News, and these adverse events are comparatively rare
prepared by licensed pharmacies on individual prescriptions Named pharmacy partners are: Strive Compounding Pharmacy (Gilbert, AZ), Promise Pharmacy (Palm Harbor, FL), Foothills Professional Pharmacy (Tempe, AZ) GLP-1 options include: Compounded semaglutide injections, compounded tirzepatide injections, liquid drops, lozenges, and Foundayo (FDA-approved oral GLP-1) Brand-name access: Wegovy and Zepbound are available through third-party pharmacies including LillyDirect or NovoCare after Provider approval
Your exact results depend on your starting point, dosage progression, and commitment to the plan your provider recommends